Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Fitzgerald

Showing results (451-460 of 629) with videos related to

Pageof 63
Sort By:
Allergology International : Official Journal of the Japanese Society of Allergology|November 13, 2017
Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthmaKen Ohta, Mitsuru Adachi, Yuji Tohda, et al.
The Lancet. Respiratory Medicine|May 27, 2017
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trialGary T Ferguson, J Mark FitzGerald, Eugene R Bleecker, et al.
Lancet (London, England)|September 10, 2016
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β<sub>2</sub>-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trialEugene R Bleecker, J Mark FitzGerald, Pascal Chanez, et al.
Annals of Surgery|January 19, 2016
Return to Work and Functional Outcomes After Major Trauma: Who Recovers, When, and How Well?Belinda J Gabbe, Pamela M Simpson, James E Harrison, et al.
Annals of the American Thoracic Society|May 12, 2021
Positioning As-needed Budesonide-Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2Eric D Bateman, Paul M O'Byrne, J Mark FitzGerald, et al.
Annals of Intensive Care|September 14, 2020
A preliminary study of intensivist-performed DVT ultrasound screening in trauma ICU patients (APSIT Study)Lloyd Roberts, Tom Rozen, Deirdre Murphy, et al.
The New England Journal of Medicine|May 17, 2018
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild AsthmaEric D Bateman, Helen K Reddel, Paul M O'Byrne, et al.
BMJ Open Quality|December 13, 2023
Opportunities to improve asthma and COPD prevention and care: insights from the patient journey obtained through focus groupsAneisha Collins-Fairclough, Karen Rideout, Phalgun Joshi, et al.
BMC Genomics|January 8, 2017
Enumerateblood - an R package to estimate the cellular composition of whole blood from Affymetrix Gene ST gene expression profilesCasey P Shannon, Robert Balshaw, Virginia Chen, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2017
Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary DiseaseWan C Tan, Jean Bourbeau, Shawn D Aaron, et al.
Pageof 63

Showing results (451-460 of 629) with videos related to

Sort By:
Pageof 63
Allergology International : Official Journal of the Japanese Society of Allergology|November 13, 2017
Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthmaKen Ohta, Mitsuru Adachi, Yuji Tohda, et al.
The Lancet. Respiratory Medicine|May 27, 2017
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trialGary T Ferguson, J Mark FitzGerald, Eugene R Bleecker, et al.
Lancet (London, England)|September 10, 2016
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β<sub>2</sub>-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trialEugene R Bleecker, J Mark FitzGerald, Pascal Chanez, et al.
Annals of Surgery|January 19, 2016
Return to Work and Functional Outcomes After Major Trauma: Who Recovers, When, and How Well?Belinda J Gabbe, Pamela M Simpson, James E Harrison, et al.
Annals of the American Thoracic Society|May 12, 2021
Positioning As-needed Budesonide-Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2Eric D Bateman, Paul M O'Byrne, J Mark FitzGerald, et al.
Annals of Intensive Care|September 14, 2020
A preliminary study of intensivist-performed DVT ultrasound screening in trauma ICU patients (APSIT Study)Lloyd Roberts, Tom Rozen, Deirdre Murphy, et al.
The New England Journal of Medicine|May 17, 2018
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild AsthmaEric D Bateman, Helen K Reddel, Paul M O'Byrne, et al.
BMJ Open Quality|December 13, 2023
Opportunities to improve asthma and COPD prevention and care: insights from the patient journey obtained through focus groupsAneisha Collins-Fairclough, Karen Rideout, Phalgun Joshi, et al.
BMC Genomics|January 8, 2017
Enumerateblood - an R package to estimate the cellular composition of whole blood from Affymetrix Gene ST gene expression profilesCasey P Shannon, Robert Balshaw, Virginia Chen, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2017
Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary DiseaseWan C Tan, Jean Bourbeau, Shawn D Aaron, et al.
Pageof 63